✦ LIBER ✦

Effect of adding Mycophenolate mofetil in paediatric renal transplant recipients with chronical cyclosporine nephrotoxicity

✍ Scribed by Guido Filler; Jutta Gellermann; Miriam Zimmering; Ingrid Mai

Publisher: Springer
Year: 2000
Tongue: English
Weight: 104 KB
Volume: 13
Category: Article
ISSN: 0934-0874
DOI: 10.1007/s001470050687

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Elective withdrawal of mycophenolate mof

Elective withdrawal of mycophenolate mofetil in renal transplant recipients treated with mycophenolate mofetil, cyclosporine, and prednisone

✍ Cornelis G. ter Meulen; Peter J. H. Smak Gregoor; Willem Weimar; Luuk B. Hilbran 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 49 KB

Conversion of liver transplant recipient

Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil

✍ Herrero, J. Ignacio ;Quiroga, Jorge ;Sangro, Bruno ;Girala, Marcos ;Gómez-Manero 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 93 KB 👁 1 views

The management of liver transplant recipients with renal function impairment remains controversial because cyclosporine withdrawal from triple immunosuppression regimens may be followed by graft rejection. A nonnephrotoxic and powerful immunosuppressant such as mycophenolate mofetil (MMF) could allo

Economic evaluation of everolimus versus

Economic evaluation of everolimus versus mycophenolate mofetil in combination with cyclosporine and prednisolone in de novo renal transplant recipients

✍ Michael Holmes; Jim Chilcott; Stephen Walters; Simon Whitby; Ron Akehurst 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 170 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of mycophenolic acid in stable renal transplant recipients treated with low doses of mycophenolate mofetil

✍ M. Brunet; J. Martorell; F. Oppenheimer; J. Vilardell; O. Millán; M. Carrillo; I 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 98 KB

Long-term efficacy and safety of mycophe

Long-term efficacy and safety of mycophenolate mofetil in liver transplant recipients with calcineurin inhibitor-induced renal dysfunction

✍ Robert O. Koch; Ivo W. Graziadei; Frank Schulz; Karin Nachbaur; Alfred Königsrai 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 234 KB

Mycophenolate mofetil in combination wit

Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation

✍ Georges-Philippe Pageaux; Lionel Rostaing; Yvon Calmus; Christophe Duvoux; Clair 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

The purpose of the study was to introduce mycophenolate mofetil (MMF) in liver transplant recipients with renal dysfunction to decrease calcineurin inhibitor (CNI) dosages without increasing rejection risk. In this prospective, multicenter, randomized study, chronic CNI-related renal dysfunction was